David P Bonita Insider Trading $IKNA Ikena Oncology, Inc.
Get free email notifications about insider trading for David P Bonita.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David P Bonita. David P Bonita is Director in AMBIT BIOSCIENCES CORP ($AMBI) and Director in SI-BONE, Inc. ($SIBN) and Director in Acutus Medical, Inc. ($AFIB) and Director in Loxo Oncology, Inc. ($LOXO) and Director in ViewRay, Inc. ($VRAY) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and Director in IMARA Inc. ($IMRA) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Repare Therapeutics Inc. ($RPTX) and Director in Ikena Oncology, Inc. ($IKNA).
David P Bonita in Ikena Oncology, Inc.
Trading Symbol: IKNAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of David P Bonita: Director
Holdings: 1,816,425 shares
Latest Transaction: Apr 01 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of David P Bonita in Ikena Oncology, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AFIB, AMBI, IKNA, IMRA, LOXO, PRLD, RPTX, SIBN, TCDA, VRAY
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 68,978 | 0 | 0 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 130,924 | 0 | 0 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 328,907 | 0 | 0 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 920,484 | 0 | 0 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 806,752 | 0 | 0 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 2,257,785 | 0 | 0 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 680,766 | 0 | 0 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | C | 0.00 | 1,905,201 | 0 | 0 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | A | 0.00 | 1,430,103 | 0 | 1,430,103 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Option Exercise | A | 0.00 | 8,938,148 | 0 | 8,938,148 | |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Buy | C | 0.00 | 130,924 | 0 | 130,924 | 0 to 130.9 K |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Buy | C | 0.00 | 5,083,470 | 0 | 5,083,470 | 0 to 5.1 M |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Buy | P | 16.00 | 48,400 | 774,400 | 117,378 | 69 K to 117.4 K (+70.17 %) |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Buy | P | 16.00 | 375,000 | 6,000,000 | 2,191,425 | 1.8 M to 2.2 M (+20.64 %) |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Buy | C | 0.00 | 68,978 | 0 | 68,978 | 0 to 69 K |
Apr 01 2021 | IKNA | Ikena Oncology, In ... | Bonita David P | Director | Buy | C | 0.00 | 1,816,425 | 0 | 1,816,425 | 0 to 1.8 M |
Page: 1